Premium
P1–027: Intracranial administration of Gammagard IVIg lowers amyloid and modulates neuroinflammatory profiles along a different time‐course than anti‐beta‐amyloid IgG: Implications for mechanism of action
Author(s) -
Wilcock Donna,
Sudduth Tiffany,
Greenstein Abigail
Publication year - 2013
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2013.05.247
Subject(s) - antibody , genetically modified mouse , hippocampus , medicine , immunology , amyloid beta , transgene , pharmacology , endocrinology , disease , chemistry , biochemistry , gene